Masteron 200 mg is an oil-based Drostanolone Enanthate injectable manufactured by Dragon Pharma and dosed at 200 mg/mL in a 10 mL vial.
Masteron 200 mg contains drostanolone enanthate, the long-acting ester variant of the DHT-derived anabolic steroid drostanolone. Drostanolone is a synthetic derivative of dihydrotestosterone, structurally modified with a 2-alpha-methyl group that prevents metabolic breakdown by 3-hydroxysteroid dehydrogenase in skeletal muscle and increases its anabolic potency. The enanthate ester extends the active life of the compound, allowing for less frequent injections compared to the propionate variant.
Drostanolone was originally developed in the late 1950s and brought to market under brand names including Masteril and Drolban for the treatment of inoperable breast cancer in women. It is no longer actively manufactured for human medical use in the United States and lacks FDA approval for any human indication. In non-medical bodybuilding contexts, Masteron 200 mg is commonly referenced for muscle hardening, density, and vascularity during cutting phases, particularly when body fat is already low.
Drostanolone does not aromatize to estrogen, which means it does not cause water retention or gynecomastia. This anti-estrogenic property is frequently cited as a reason for its popularity during pre-contest preparation. However, its androgenic nature means it can accelerate hair loss in predisposed individuals, and it does not replace the need for a testosterone base in non-medical cycles.
Masteron 200 mg uses MCT oil as its carrier, providing an oil base for the drostanolone enanthate formulation. The 200 mg/mL concentration is the standard strength for the enanthate ester.
Drostanolone enanthate is the long-acting ester of drostanolone, a DHT-derived anabolic steroid with strong androgenic properties and no estrogenic activity. Its extended release profile distinguishes it from the shorter-acting propionate ester.
Drostanolone is structurally derived from dihydrotestosterone with a 2-alpha-methyl group that increases its anabolic potency and prevents breakdown by skeletal muscle enzymes. The enanthate ester is a long-chain fatty acid attached to the 17-beta hydroxyl group that slows release from the injection site, extending the compound's active life to approximately 7-10 days.
Drostanolone binds to the androgen receptor with an affinity approximately five times greater than testosterone, which contributes to its effects on muscle hardness and potential lipolysis. It does not aromatize to estrogen and does not cause water retention.
Historically, drostanolone was used medically for breast cancer treatment, but it is no longer manufactured for human use in the United States. The enanthate ester was developed by underground laboratories as an alternative to the propionate version to reduce injection frequency.
The enanthate ester of Masteron 200 mg produces a longer duration of action than the propionate ester, typically requiring injections once or twice per week in non-medical contexts. Blood levels stabilize over approximately 2-3 weeks, with full effects becoming apparent at weeks 4-6 in lean individuals. This slower release means side effects are harder to manage quickly if they occur, which is a consideration for female users.
Dragon Pharma offers the shorter-acting version of this compound, Masteron 100, which contains drostanolone propionate at 100 mg/mL. The propionate ester requires more frequent injections but clears the body faster, which some users prefer for better control. For those seeking a non-aromatizing oral option during cutting phases, Winstrol 50 is commonly referenced in bodybuilding contexts.
Masteron is frequently combined with other compounds in non-medical cutting cycles. Dragon Pharma's Anavar 10 is sometimes stacked with Masteron for enhanced muscle preservation during caloric restriction. Masteron should not be run without a testosterone base, as it suppresses endogenous testosterone production without providing sufficient androgenic activity on its own.
Published laboratory reports for Masteron 200 mg are shown below with the test date, measured concentration and percentage of the product's 200 mg/mL label claim.
View Report
View Report
View Report
Laboratory results apply to the specific tested sample represented in each published report and should not be interpreted as a measurement of every vial or production batch.
The information below is provided for educational reference only. Drostanolone enanthate is not approved for human medical use in the United States; non-medical use falls outside any approved indications and may carry significant health risks.
In non-medical bodybuilding contexts, Masteron 200 mg is commonly referenced in the range of 200–600 mg per week, with beginners starting at the lower end and advanced users referencing higher amounts. Because of the enanthate ester, the weekly total is typically divided into injections administered once or twice per week. The 200 mg/mL concentration means that 1 mL provides 200 mg of drostanolone enanthate.
| Use Case | Common Reference Range | Injection Frequency |
|---|---|---|
| Beginner (non-medical) | 200–300 mg / week | Once or twice weekly |
| Intermediate (non-medical) | 400–500 mg / week | Twice weekly |
| Advanced (non-medical) | 500–600 mg / week | Twice weekly |
In non-medical bodybuilding contexts, drostanolone enanthate is most commonly referenced as a cutting or pre-contest compound. It is frequently stacked with a testosterone base, which provides the anabolic foundation and maintains normal physiological function. Dragon Pharma's Cypionate 250 or Enantat 250 are commonly mentioned in this context.
Because Masteron does not aromatize, it may reduce or eliminate the need for aromatase inhibitors when stacked with moderate doses of testosterone. Cycle lengths of 8–12 weeks are commonly referenced in non-medical contexts. The compound is typically introduced during the final weeks of a cutting phase when body fat is already low, as its visual effects are most apparent below 12-15% body fat.
As a DHT derivative, drostanolone enanthate can accelerate male pattern baldness in individuals who are genetically predisposed. Finasteride does not help because drostanolone is already DHT and is not metabolized by 5-alpha reductase. Acne and increased skin oiliness are also commonly referenced.
Drostanolone can negatively affect lipid profiles, reducing HDL cholesterol and potentially increasing LDL. The impact on HDL is often greater than on LDL. Blood pressure and cardiovascular markers should be monitored during use. Because it suppresses endogenous testosterone production, a testosterone base is commonly referenced in non-medical cycles.
After completing a cycle with Masteron 200 mg, post-cycle therapy is commonly recommended in non-medical contexts to help restore endogenous testosterone production. Agents such as Clomid or Nolvadex are frequently referenced for this purpose.
Because drostanolone enanthate has a longer half-life, PCT should begin approximately 2 weeks after the final injection to allow the ester to clear. Bloodwork and, where possible, medical guidance can help inform recovery strategy.
Dosing strategies, support compounds and recovery protocols should be adjusted based on experience level and bloodwork where possible. The information above is for educational reference and does not constitute medical advice.
Drostanolone enanthate is a synthetic anabolic steroid that lacks FDA approval for human use and can affect cardiovascular, endocrine and reproductive function.
Drostanolone (dromostanolone) is listed as lacking FDA approval for human use in the United States. It was historically approved for the treatment of inoperable breast cancer in women, but is no longer actively manufactured for human medical use. Non-medical use for bodybuilding or performance enhancement falls outside any approved indication and may carry significant health risks.
Anabolic steroids in general have been associated with serious adverse effects including cardiovascular complications, dyslipidemia, and endocrine disruption. Drostanolone's androgenic nature means it carries particular risks related to hair loss and virilization.
Use of drostanolone enanthate for bodybuilding or performance enhancement falls outside any approved medical indication. Higher-than-physiologic exposure can increase the risk of serious adverse effects including cardiovascular, hepatic and endocrine complications.
As a DHT derivative, drostanolone enanthate is associated with androgenic side effects including accelerated male pattern baldness, acne, and increased body hair growth. In women, virilization signs such as deepening of the voice, hirsutism, and clitoromegaly may occur and can be irreversible.
Anabolic steroids including drostanolone have been reported to affect lipid profiles, with reductions in HDL cholesterol and potential increases in LDL. These changes may have a serious impact on cardiovascular risk. Left ventricular hypertrophy and hepatotoxicity have been documented in case reports at bodybuilding doses.
Drostanolone suppresses endogenous testosterone production, which can lead to sexual dysfunction and testicular atrophy during use. Other potential effects include mood changes, irritability, and elevated blood pressure.
Drostanolone enanthate is contraindicated in certain circumstances. Known contraindications include prostate cancer, male breast cancer, pregnancy or potential for pregnancy, and known hypersensitivity to drostanolone. Caution is advised in individuals with pre-existing cardiovascular disease, hepatic impairment, or significant hair loss concerns. Untreated hypertension and dyslipidemia should be addressed before any consideration of use.
Existing cardiovascular disease, liver conditions, prostate conditions, and other medical conditions should be discussed with a qualified healthcare professional before drostanolone is considered.
If drostanolone enanthate is used in any context, monitoring of lipid profiles and cardiovascular markers is important given the compound's known effects on HDL cholesterol. Blood pressure, hematocrit, and liver function may also warrant monitoring. In non-medical bodybuilding contexts, bloodwork before, during, and after a cycle is commonly referenced as a risk-reduction strategy.
Keep the vial securely stored and protected from conditions that could compromise the product or container. Store at controlled room temperature (20°–25°C) and protect from light. Inspect the vial and solution before use and do not use a product that appears damaged, contaminated or otherwise abnormal.
Keep all medications and injectable products out of the reach of children. Follow the storage instructions provided with the product packaging.
Masteron 200 mg by Dragon Pharma is shipped in original manufacturer packaging with discreet, privacy-focused handling.
The outer shipping package remains discreet, with privacy-focused handling and no unnecessary external product details.
To verify your Masteron 200 mg product, use the security code on the vial label and cross-check it on the Dragon Pharma official site. Original Dragon Pharma packaging and batch-linked lab proof help reinforce product legitimacy.
For complete delivery details, tracking policy, and reshipment terms, please see our Shipping Info page.
Proper storage conditions help preserve formulation stability and overall product integrity throughout shelf life.
Store at controlled room temperature (15–25°C) and protect from excessive heat, moisture, and direct light. Maintaining stable conditions helps preserve the integrity of the oily formulation.
Keep the vial in its original packaging until use. Do not freeze. Before administration, inspect the solution and avoid use if it appears cloudy, discolored, contains particulate matter, or if the vial or seal is compromised.
Keep out of reach of children. Follow proper handling and sterile injection practices when administering the product.
Answers to common questions about Masteron 200 mg, drostanolone enanthate, usage considerations, product strength and laboratory testing.
Masteron 200 mg contains drostanolone enanthate, which was historically used for the treatment of inoperable breast cancer in women. In non-medical bodybuilding settings, Masteron 200 mg is commonly referenced for muscle hardness, density, and vascularity during cutting phases, though such use falls outside any approved medical indication.
Because of its enanthate ester, drostanolone enanthate is typically referenced as being administered once or twice per week in non-medical contexts. The 200 mg/mL concentration means that 1 mL provides 200 mg of drostanolone enanthate.
In non-medical bodybuilding contexts, post-cycle therapy is commonly recommended after a drostanolone enanthate cycle to help restore endogenous testosterone production. Agents such as Clomid or Nolvadex are commonly referenced for this purpose. Because of the longer enanthate ester, PCT should begin approximately 2 weeks after the final injection.
Drostanolone enanthate is a DHT-derived anabolic steroid that binds to the androgen receptor with high affinity and promotes nitrogen retention, increases protein anabolism, and decreases amino acid catabolism. It does not aromatize to estrogen, which distinguishes it from testosterone and many other anabolic steroids.
Because of its enanthate ester, drostanolone enanthate reaches stable blood levels over approximately 2-3 weeks. In non-medical contexts, users commonly reference noticing effects on muscle hardness and vascularity at weeks 4-6 of use, particularly when body fat is already low.
There is no single compound that is universally best for cutting. Masteron 200 mg is commonly referenced in bodybuilding contexts for its ability to promote muscle hardness and vascularity without water retention. Other products such as Winstrol 50 and Anavar 10 are also referenced for cutting purposes.
The primary difference is the ester and concentration. Masteron 100 mg contains drostanolone propionate at 100 mg/mL, which is a short-acting ester requiring frequent injections. Masteron 200 mg contains drostanolone enanthate at 200 mg/mL, which is a longer-acting ester requiring less frequent injections. Both ultimately provide the same parent hormone, drostanolone.
Masteron 200 mg contains drostanolone enanthate, an injectable DHT-derived anabolic steroid. Proviron contains mesterolone, an oral DHT-derived compound with different pharmacokinetic properties. Both are referenced in bodybuilding contexts, but they have distinct administration routes and characteristics.
A milligram amount cannot be classified as appropriate or excessive without considering the specific context, individual response, and other factors. In non-medical bodybuilding contexts, drostanolone enanthate is commonly referenced in the 200–600 mg per week range, divided into one or two injections per week. Such use falls outside approved indications.
Masteron 200 mg is labeled at 200 mg of drostanolone enanthate per mL. It is supplied in a 10 mL vial, giving 2,000 mg of total labeled drostanolone enanthate content per vial.
Yes. A published laboratory report dated August 25, 2026 measured Masteron 200 mg at 201.77 mg, equivalent to 100.89% of its 200 mg/mL label claim.
The complete report can be viewed in the Lab Reports tab. Laboratory results apply to the tested sample represented by the individual report and should not be interpreted as a measurement of every vial.
Drostanolone enanthate is generally referenced as an intermediate-to-advanced compound in non-medical bodybuilding contexts. Its androgenic nature and the requirement for a testosterone base make it less suitable as a first compound. Users typically have experience with testosterone-based cycles before considering Masteron.